These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 29516289)

  • 1. Are Doctors the Best People to Manage Gout? Is There a Role for Nurses and Pharmacists?
    Latif Z; Abhishek A
    Curr Rheumatol Rep; 2018 Mar; 20(3):14. PubMed ID: 29516289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial.
    Doherty M; Jenkins W; Richardson H; Sarmanova A; Abhishek A; Ashton D; Barclay C; Doherty S; Duley L; Hatton R; Rees F; Stevenson M; Zhang W
    Lancet; 2018 Oct; 392(10156):1403-1412. PubMed ID: 30343856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implication of nurse intervention on engagement with urate-lowering drugs: A qualitative study of participants in a RCT of nurse led care.
    Latif ZP; Nakafero G; Jenkins W; Doherty M; Abhishek A
    Joint Bone Spine; 2019 May; 86(3):357-362. PubMed ID: 30394337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence and Outcomes with Urate-Lowering Therapy: A Site-Randomized Trial.
    Mikuls TR; Cheetham TC; Levy GD; Rashid N; Kerimian A; Low KJ; Coburn BW; Redden DT; Saag KG; Foster PJ; Chen L; Curtis JR
    Am J Med; 2019 Mar; 132(3):354-361. PubMed ID: 30503879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and design of the randomized evaluation of an Ambulatory Care Pharmacist-Led Intervention to Optimize Urate Lowering Pathways (RAmP-UP) Study.
    Coburn BW; Cheetham TC; Rashid N; Chang JM; Levy GD; Kerimian A; Low KJ; Redden DT; Bridges SL; Saag KG; Curtis JR; Mikuls TR
    Contemp Clin Trials; 2016 Sep; 50():106-15. PubMed ID: 27449546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring current and potential roles of Australian community pharmacists in gout management: a qualitative study.
    Counsell AB; Nguyen AD; Baysari MT; Kannangara DRW; McLachlan AJ; Day RO
    BMC Fam Pract; 2018 May; 19(1):54. PubMed ID: 29743018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nurse-led care is preferred over GP-led care of gout and improves gout outcomes: results of Nottingham Gout Treatment Trial follow-up study.
    Fuller A; Jenkins W; Doherty M; Abhishek A
    Rheumatology (Oxford); 2020 Mar; 59(3):575-579. PubMed ID: 31410473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term persistence and adherence on urate-lowering treatment can be maintained in primary care-5-year follow-up of a proof-of-concept study.
    Abhishek A; Jenkins W; La-Crette J; Fernandes G; Doherty M
    Rheumatology (Oxford); 2017 Apr; 56(4):529-533. PubMed ID: 28082620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How Can We Improve Disease Education in People with Gout?
    Fields TR; Batterman A
    Curr Rheumatol Rep; 2018 Mar; 20(3):12. PubMed ID: 29516200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New developments in gout.
    Harrold L
    Curr Opin Rheumatol; 2013 May; 25(3):304-9. PubMed ID: 23466959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Professionals' perspectives on existing practice and conditions for nurse-led gout care based on treatment recommendations: a qualitative study in primary healthcare.
    Sedelius H; Tistad M; Bergsten U; Dehlin M; Iggman D; Wallin L; Svärd A
    BMC Prim Care; 2022 Apr; 23(1):71. PubMed ID: 35392809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of gout at an academic healthcare center in Beijing: a physician survey.
    Fang W; Zeng X; Li M; Chen LX; Schumacher HR; Zhang F
    J Rheumatol; 2006 Oct; 33(10):2041-9. PubMed ID: 17014019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming adherence issues and other barriers to optimal care in gout.
    Nasser-Ghodsi N; Harrold LR
    Curr Opin Rheumatol; 2015 Mar; 27(2):134-8. PubMed ID: 25633242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Gout in a Hospital Setting: A Lost Opportunity.
    Wright S; Chapman PT; Frampton C; O'Donnell JL; Raja R; Stamp LK
    J Rheumatol; 2017 Oct; 44(10):1493-1498. PubMed ID: 28765252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The patient's experience of gout: new insights to optimize management.
    Dalbeth N; Lindsay K
    Curr Rheumatol Rep; 2012 Apr; 14(2):173-8. PubMed ID: 22198831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient and clinical characteristics associated with gout flares in an integrated healthcare system.
    Rashid N; Levy GD; Wu YL; Zheng C; Koblick R; Cheetham TC
    Rheumatol Int; 2015 Nov; 35(11):1799-807. PubMed ID: 25991397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient perspectives in gout: a review.
    Singh JA
    Curr Opin Rheumatol; 2019 Mar; 31(2):159-166. PubMed ID: 30575598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence and persistence to urate-lowering therapies in the Irish setting.
    McGowan B; Bennett K; Silke C; Whelan B
    Clin Rheumatol; 2016 Mar; 35(3):715-21. PubMed ID: 25409858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gout.
    Dalbeth N; Merriman TR; Stamp LK
    Lancet; 2016 Oct; 388(10055):2039-2052. PubMed ID: 27112094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What Is the Evidence for Treat-to-Target Serum Urate in Gout?
    Bursill D; Dalbeth N
    Curr Rheumatol Rep; 2018 Mar; 20(3):11. PubMed ID: 29516287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.